Grafa News and Videos — Page 1160

Savara (NASDAQ:SVRA), a clinical-stage biopharmaceutical company dedicated to rare respiratory diseases, announced on April 7, 2026, that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has accepted its Marketing Authorisation Application (MAA) for MOLBREEVI.

Fluor (NYSE:FLR) announced on April 7, 2026, that it has been selected by America First Refining (AFR) to execute the front-end engineering and design (FEED) for a landmark large-scale refining facility in Brownsville, Texas.

Gilead Sciences (NASDAQ:GILD) announced on April 7, 2026, that it has entered into a definitive agreement to acquire Tubulis GmbH, a private German biotechnology company specializing in next-generation antibody-drug conjugates (ADCs).

Jaguar Health (NASDAQ:JAGX), a commercial-stage pharmaceutical company focused on gastrointestinal products, released its consolidated financial results for the fourth quarter and full year ended December 31, 2025, on April 7, 2026.

Outlook Therapeutics (NASDAQ:OTLK), a biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab, announced on April 7, 2026, that the U.S. Food and Drug Administration (FDA) has accepted its Formal Dispute Resolution Request (FDRR) regarding ONS-5010/LYTENAVA™ (bevacizumab-vikg).

Bit Digital (NASDAQ:BTBT), a high-performance computing and digital asset mining company, has released its monthly treasury and staking update for March 2026, highlighting a significant Ethereum position and active yield-generation strategy.

Halozyme Therapeutics (NASDAQ:HALO) and Vertex Pharmaceuticals (NASDAQ:VRTX) announced a global exclusive collaboration and license agreement on April 7, 2026, aimed at leveraging Halozyme’s proprietary Hypercon™ microparticle technology to transform the delivery of biologic therapies.

Alzamend Neuro (NASDAQ:ALZN), a clinical-stage biopharmaceutical company focused on developing novel products for neurological disorders, reported preliminary pharmacodynamic data on April 7, 2026, from a healthy-subject study evaluating its lead candidate, AL001.

Booz Allen Hamilton (NYSE:BAH) announced on April 7, 2026, the successful completion of its acquisition of Defy Security, a move aimed at consolidating its position as a dominant provider of high-speed, tech-enabled cybersecurity services for both commercial and government sectors.

Academy Sports + Outdoors (NASDAQ:ASO) issued a preliminary sales update for the first quarter of fiscal 2026 on April 7, 2026, signaling a robust start to the year ahead of its scheduled Analyst Day in Katy, Texas.